In this study, utilising functional ex vivo assays and deep immunophenotyping techniques we explore the role of Bregs in the development of severe immune-related adverse events (irAE) in lung cancer patients treated with anti-PD-1/PD-L1. This evidence concerns the gene CD274 and lung carcinoma.